TP53 and cancer: RITA has since also been found to suppress growth in a number of different cancers with mutant p53 such as colon, lung and breast carcinoma as well as Burkitt lymphoma with mutations at residues—273, 175 and 248, 280, 213, 234, 283, 254 and 125 [56].